* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Lida Bun 10/31/2012 Brother Thomas McPhillips Microbiology in the News •Virus family: Caliciviridae •Nucleic Acid: RNA (+ sense) •Disease caused: Enteric non-A, non-B hepatitis •Size: 30-35 nm, icosahedral •Envelope: Non-envelope •Incubation period: 3-8 weeks •Transmission: The hepatitis E virus is transmitted mainly through the faecal-oral route due to faecal contamination of drinking water. •Ingestion of contaminated meat •Transmission to pregnant woman to her fetus •Transfusion of infected blood •20 million cases of infection per year. •3 million acute illnesses and 70,000 deaths annually •Common in people 15 to 40 yrs old. •Hepatitis E is prevalent in most developing countries. •Particularly chronic in pregnant women. •Symptoms No treatment as of right now “Self-limiting” disease Support Prevention Recombinant Hepatitis E Vaccine (Escherichia Coli) Developed by Xiamen University and Xiamen Innovax Biotech Co. Ltd First China’s State Food and Drug Administration (CSFDA) approved vaccine affective for HEV under mass production. Inoculation of this product can stimulate the body to produce immunity against hepatitis E virus for the prevention of hepatitis E. This product is suitable for susceptible population aged 16 and above.